DateInvalid Date
Read Time1 min
Strategic Investment in a Leading Dividend ETF
Amidst global uncertainties, a strategic investment in the Schwab U.S. Dividend Equity ETF is highlighted as a prudent choice. This ETF focuses on high-yielding dividend stocks, offering stability and income. Its diverse portfolio includes sectors like energy and defense, positioning it well to navigate market fluctuations and geopolitical tensions, making it an attractive option for long-term investors seeking both resilience and growth.

By Natalie PaceApr 23, 2026
Tesla's Unwavering Bitcoin Bet: Holding Strong Amidst Market Swings
Despite significant price fluctuations in the first quarter of this year, electric vehicle giant Tesla has maintained its substantial Bitcoin holdings. The company continues to possess 11,509 BTC, valued at approximately $895 million, as revealed in its latest financial disclosures. This steadfast approach comes even as Bitcoin experienced a notable decline, resulting in an impairment loss for Tesla. The firm's long-term commitment to the cryptocurrency, initiated in 2021, remains a key aspect of its financial strategy, underscoring a belief in the digital asset's enduring value.

By Mr. Money MustacheApr 23, 2026
Baker Hughes Expected to Announce Reduced Q1 Earnings; Analysts Revise Forecasts
Baker Hughes (NASDAQ: BKR) is set to release its first-quarter earnings report on Thursday, April 23. Analysts anticipate a slight decrease in earnings per share to 49 cents from 51 cents in the previous year, with revenue projected at $6.33 billion. The company recently agreed to sell its Waygate Technologies business to Hexagon (OTC: HXGBY) for approximately $1.45 billion. Several analysts have updated their ratings and price targets for Baker Hughes ahead of the earnings call.

By Natalie PaceApr 23, 2026
ICON Public Limited Company: An Undervalued Investment Opportunity
White Brook Capital Partners' Q1 2026 investor letter highlights ICON Public Limited Company (ICLR) as a potentially undervalued stock. Despite a recent revenue recognition investigation that caused a significant stock drop, the clinical research organization maintains strong fundamentals, a substantial backlog, and favorable positioning in high-growth therapeutic areas like oncology and GLP-1/obesity. The firm believes ICLR's current valuation significantly underestimates its business strength and anticipates a rally once financial clarity is re-established.

By Dave RamseyApr 23, 2026
S&P Global's Growth Potential and Defensive Resilience Highlighted by White Brook Capital
White Brook Capital Partners' Q1 2026 investor letter emphasizes S&P Global's robust growth prospects and defensive stability. Despite a challenging economic environment marked by military actions and AI uncertainties, the firm acquired SPGI shares during a market dip, confident in its enduring value as a provider of critical financial services amidst evolving market dynamics.

By Mr. Money MustacheApr 23, 2026